Cabaletta Bio

Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced plans to showcase updated clinical data on its investigational CD19-CAR T cell therapy, resecabtagene autoleucel (rese-cel), during two prominent scientific conferences this …

Cabaletta Bio to Present Pioneering Clinical Data on Rese-cel at Major Scientific Conferences Read More



Virpax Pharmaceuticals

Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that Matthew Barnes, the company’s senior director of portfolio management, will be presenting at the Outsourcing in Clinical Trials (OCT) Conference. …

Virpax Pharmaceuticals Highlights Leadership Contributions at Clinical Trial Conference Read More